Exploratory Study for Allergy Relief Onset

See also
Status	Clinical Trial	Phase
Completed	`NCT02424539` - A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)	Phase 4
Completed	`NCT02486159` - The Oligonucleotide Chip Analysis for Allergic Rhinitis Treatment in Herbal Plaster and Acupuncture	N/A
Completed	`NCT00770315` - Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234)	Phase 3
Completed	`NCT00771160` - MK0476 Study in Adult Patients With Perennial Allergic Rhinitis (0476-397)(COMPLETED)	Phase 3
Completed	`NCT00834119` - Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270)	Phase 4
Recruiting	`NCT04435990` - Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites	Phase 3
Recruiting	`NCT05177744` - Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Allergic Disease
Recruiting	`NCT05621356` - Monitoring Allergen Immunotherapy in Allergic Rhinitis
Not yet recruiting	`NCT06330974` - Allergy, Asthma, and Atopic Eczema in Finland
Completed	`NCT03758456` - HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human	Phase 1
Completed	`NCT04645979` - A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico
Completed	`NCT05122143` - Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers	N/A
Completed	`NCT05901532` - Nasal Irrigation With Chinese Herbal Medicine as an Adjunctive Treatment in Allergic Rhinitis	Phase 2
Recruiting	`NCT05656482` - Ability of a Cat Food to Reduce Respiratory Symptoms in Cat Allergic Patients
Recruiting	`NCT04898283` - Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.	Phase 3
Recruiting	`NCT06436534` - Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic Rhinitis	N/A
Recruiting	`NCT05922176` - Biomarker Screening for Immunotherapy Response Evaluation Using Microneedle Patch in Patients With Allergic Rhinitis
Completed	`NCT02679105` - Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous Immunotherapy	Phase 2/Phase 3
Completed	`NCT01104012` - Validation of Proteomic Analyses for Allergic Asthma and Rhinitis	N/A
Completed	`NCT03375775` - Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children	N/A

NCT number	NCT02722083
Study type	Interventional
Source	Bayer
Contact
Status	Terminated
Phase	Phase 2
Start date	May 7, 2016
Completion date	July 13, 2016

Exploratory Study for Allergy Relief Onset

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms